SAS | The Power to Know

The forum is now full to attend in person. However, registration is still open for live streaming the event online.

Time 
9:00 - 9:15Welcome
Mark Wilkinson, Managing Director of SAS UK and Ireland.
9:15 - 10:00Keynote address: Sue Forda (European Federation of Pharmaceutical Industries and Associations, Eli Lilly) : "The European Pharmaceutical Industry's drive to responsible clinical trial data sharing"
10:00 - 10:20Andrew Freeman (GSK) – "Sharing clinical trial data to external researchers to foster collaboration and innovation in research and development."
10:20 - 10:40Ulla Outrup (NovoNordisk) – “Clinical Trial Data Transparency at Novo Nordisk”
10:40 - 11:00Coffee break
11:15 - 11:45Sarah Nolan, University Liverpool – "An Academic Researcher's Perspective on Data Transparency"
11:45 - 12:30
Panel Discussion
Strategic aspects of clinical trial data transparency projects : implementation track, benefits, risks, concerns in adopting, lessons learned, perspective of companies that are still considering to join (confirmed participants : Ulla Outrup, VP Clinical NovoNordisk, Sue Forda EFPIA/Eli Lilly, Karla Childers (J&J), Sarah Nolan (University Liverpool), Andrew Freeman (GSK), other participants to be announced.
12:30 - 13:30Lunch

 

Part 2
Operational aspects of clinical trial data transparency projects

Time 
13:30 - 14:00"Overview of J&J agreement with the Yale Open Data Access (YODA) Project"
Karla Childers, Director of Strategic Projects in the office of the CMO at Johnson & Johnson.
14:00 - 14:453 parallel break-out sessions:
  1. Multi-sponsor environment : characteristics, structure, collaboration, independent review panel requirements
  2. Quality criteria for secondary analysis by external researchers – publication rules of their results
  3. Transparency and the regulatory environment - European draft law, EMEA guidance and impact on industry initiatives.
14:45 - 15:00Coffee break and bringing together results of break-out sessions
15:00 - 15:20Gregory Steffens (Novartis): Patient data de-identification in practice
15:20 - 16:00Panel discussion
Operational aspects of data transparency- Patient data de-identification, data readying and standardization, implication of clinical data management, processes from application to granting access for researcher, analytical tools required.
16:00 - 16:10Matt Gross (SAS): "Clinical Trial Data Transparency – summary of the day"
16:10 - 16:20
Closing remarks by Bert Boers (SAS) – Vice-President for Southwest Europe, Executive Sponsor Life Sciences EMEA at SAS
16:20 - 17:30Closing Reception: Wine & Cheese.

 

 

Date:
Tuesday 29 April 2014

Time:
09:00 - 17:00

Location:
SAS UK,
Marlow,
Buckinghamshire,
SL7 2EB
View Map

 

Questions?
Please contact
Cindy Etsell 07918724381 or Lizzie Brown 01628 490790

Back to Top